| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, Dallas VA Medical Center and University of Texas-Southwestern Medical School, Dallas, TX, USA; Department of Surgery, Dallas VA Medical Center and University of Texas-Southwestern Medical School, Dallas, TX, USA; the Harold C. Simmons Comprehensive Cancer Center (R.F.S.) and the Hamon Center for Therapeutic Oncology Research, University of Texas-Southwestern Medical Center at Dallas, Dallas, TX, USA
* To whom correspondence should be addressed. E-mail: rsouza{at}airmail.net.
Cyclooxygenase-2 (COX-2) has been linked to neoplastic progression in Barrett's esophagus. Acid exposure has been shown both to activate the mitogen-activated protein kinase (MAPK) pathways and to increase COX-2 protein expression in Barrett's metaplasia, but it is not known if these effects are interrelated. We hypothesized that acid-induced activation of the MAPK pathways mediates an increase in COX-2 expression in Barrett's esophagus, and we tested this hypothesis in a Barrett's-associated adenocarcinoma cell line (SEG-1). We exposed SEG-1 cells to acidic or neutral media in the presence and absence of two MAPK inhibitors: U0126 (an ERK inhibitor) or SB203580 (a p38 inhibitor). We quantitated COX-2 protein levels using an EIA assay, and COX-2 mRNA levels using real-time PCR. We also determined how acid affects the activity of the COX-2 promoter and mRNA stability. Compared to SEG-1 cells exposed to neutral media, acid-exposed cells exhibited a 2.8-fold increase in COX-2 mRNA levels within 30 minutes. Both U0126 and SB203580 attenuated the acid-induced increase in COX-2 mRNA. Acid significantly increased COX-2 protein expression and promoter activity, and both of these effects were abolished by treatment with U0126 and SB203580. Acid exposure also stabilized COX-2 mRNA levels, an effect that was abolished by U0126 but not by SB203580. We conclude that acid increases COX-2 expression through activation of the MAPK pathways. Acid-induced activation of both ERK and p38 causes a significant increase in COX-2 promoter activity, and acid-activated ERK stabilizes COX-2 mRNA. These findings suggest potential mechanisms whereby acid reflux might promote carcinogenesis in Barrett's esophagus.
This article has been cited by other articles:
|
|
 |
|
  R. C Fitzgerald Epigenetic changes wipe out protective mechanisms in Barrett's oesophagus Gut, January 1, 2009; 58(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Abrams Review: Chemoprevention of esophageal adenocarcinoma Therapeutic Advances in Gastroenterology, July 1, 2008; 1(1): 7 - 18. [Abstract] [PDF]
|
|
|
|
|
|
S. Song, S. Guha, K. Liu, N. S Buttar, and R. S Bresalier COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma Gut, November 1, 2007; 56(11): 1512 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W.P.M. van Baal, S. H. Diks, R. J.A. Wanders, A. M. Rygiel, F. Milano, J. Joore, J. J.G.H.M. Bergman, M. P. Peppelenbosch, and K. K. Krishnadath Comparison of Kinome Profiles of Barrett's Esophagus with Normal Squamous Esophagus and Normal Gastric Cardia Cancer Res., December 15, 2006; 66(24): 11605 - 11612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Feagins, N. Susnow, H. Y. Zhang, S. Pearson, C. Owen, W. F. Schmalstieg, L. S. Terada, S. J. Spechler, R. D. Ramirez, and R. F. Souza Gain of allelic gene expression for IGF-II occurs frequently in Barrett's esophagus Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G871 - G875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Oliver III, E. Friday, F. Turturro, A. Lacy, and T. Welbourne Troglitazone's rapid and sustained activation of ERK1/2 induces cellular acidosis in LLC-PK1-F+ cells: physiological responses Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1257 - F1266. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
